AstraZeneca unveils $37bn U.S. investment plan amid tariff threats Health AstraZeneca unveils $37bn U.S. investment plan amid tariff threats Agency Report July 22, 2025 British-based drug maker AstraZeneca has announced plans to invest 50 billion dollars in the United States over...Read More